Summary of individual Treg product characteristics before and after expansion
UPN* . | Before expansion . | After expansion . | ||||||
---|---|---|---|---|---|---|---|---|
Pre-CD25 selection TNC (×108) . | Post-CD25 selection . | TNC (×106) . | % CD4+CD25+ . | Absolute CD4+CD25+ (×106) . | Fold expansion . | Suppression at 1:4 ratio . | ||
TNC (×106) . | % CD4+CD25+ . | |||||||
4689 | 27 | 6.51 | 44 | 7610 | 71 | 5403 | 1169 | 80 |
4741 | 13 | 7.26 | 49 | 5452 | 74 | 4034 | 751 | 79 |
4762 | 8 | 2.50 | 71 | 148 | 95 | 141 | 59 | 81 |
4778 | 16 | 6.60 | 60 | 1280 | 73 | 934 | 194 | 78 |
4837 | 34 | 19.20 | 63 | 11309 | 93 | 10517 | 589 | 86 |
4855 | 14 | 5.20 | 49 | 1030 | 95 | 979 | 198 | 87 |
4872 | 22 | 2.39 | 83 | 2261 | 97 | 2193 | 946 | NA |
4908 | 22 | 7.31 | 80 | 2880 | 95 | 2796 | 394 | 81 |
4915 | 19 | 8.40 | 82 | 1058 | 62 | 656 | 126 | 95 |
4930 | 21 | 4.44 | 87 | 937 | 91 | 853 | 211 | 39 |
4936 | 14 | 0.74 | 54 | 286 | 76 | 217 | 385 | 86 |
4963 | 16 | 7.23 | 58 | 2458 | 81 | 1991 | 340 | 89 |
4975 | 15 | 4.68 | 73 | 1039 | 87 | 904 | 222 | 87 |
5013 | 16 | 1.70 | 11 | 129 | 69 | 89 | 76 | 94 |
4654 | 17 | 9.66 | 69 | 753 | 96 | 723 | 78 | 89 |
5039 | 16 | 9.15 | 62 | 119 | 80 | 95 | 13 | 86 |
5002 | 18 | 5.40 | 59 | 151 | 86 | 130 | 28 | 87 |
5087 | 16 | 17.50 | 66 | 3290 | 95 | 3126 | 188 | 75 |
5083 | 16 | 9.90 | 61 | 1020 | 84 | 857 | 103 | 86 |
5117 | 16 | 3.30 | 67 | 1580 | 78 | 1232 | 476 | 74 |
5121 | 23 | 1.13 | 65 | 12500 | 87 | 10875 | 1106 | 85 |
5125 | 22 | 9.02 | 70 | 16200 | 78 | 12636 | 1796 | 49 |
5151 | 15 | 7.20 | 76 | 1230 | 88 | 1082 | 171 | 60 |
Median (range) | 16 (8-34) | 6.6 (0.74-19.2) | 65 (11-87) | 1230 (119-16 200) | 86 (62-97) | 1058 (74-12636) | 211 (13-1796) | 85.5 (39-95) |
UPN* . | Before expansion . | After expansion . | ||||||
---|---|---|---|---|---|---|---|---|
Pre-CD25 selection TNC (×108) . | Post-CD25 selection . | TNC (×106) . | % CD4+CD25+ . | Absolute CD4+CD25+ (×106) . | Fold expansion . | Suppression at 1:4 ratio . | ||
TNC (×106) . | % CD4+CD25+ . | |||||||
4689 | 27 | 6.51 | 44 | 7610 | 71 | 5403 | 1169 | 80 |
4741 | 13 | 7.26 | 49 | 5452 | 74 | 4034 | 751 | 79 |
4762 | 8 | 2.50 | 71 | 148 | 95 | 141 | 59 | 81 |
4778 | 16 | 6.60 | 60 | 1280 | 73 | 934 | 194 | 78 |
4837 | 34 | 19.20 | 63 | 11309 | 93 | 10517 | 589 | 86 |
4855 | 14 | 5.20 | 49 | 1030 | 95 | 979 | 198 | 87 |
4872 | 22 | 2.39 | 83 | 2261 | 97 | 2193 | 946 | NA |
4908 | 22 | 7.31 | 80 | 2880 | 95 | 2796 | 394 | 81 |
4915 | 19 | 8.40 | 82 | 1058 | 62 | 656 | 126 | 95 |
4930 | 21 | 4.44 | 87 | 937 | 91 | 853 | 211 | 39 |
4936 | 14 | 0.74 | 54 | 286 | 76 | 217 | 385 | 86 |
4963 | 16 | 7.23 | 58 | 2458 | 81 | 1991 | 340 | 89 |
4975 | 15 | 4.68 | 73 | 1039 | 87 | 904 | 222 | 87 |
5013 | 16 | 1.70 | 11 | 129 | 69 | 89 | 76 | 94 |
4654 | 17 | 9.66 | 69 | 753 | 96 | 723 | 78 | 89 |
5039 | 16 | 9.15 | 62 | 119 | 80 | 95 | 13 | 86 |
5002 | 18 | 5.40 | 59 | 151 | 86 | 130 | 28 | 87 |
5087 | 16 | 17.50 | 66 | 3290 | 95 | 3126 | 188 | 75 |
5083 | 16 | 9.90 | 61 | 1020 | 84 | 857 | 103 | 86 |
5117 | 16 | 3.30 | 67 | 1580 | 78 | 1232 | 476 | 74 |
5121 | 23 | 1.13 | 65 | 12500 | 87 | 10875 | 1106 | 85 |
5125 | 22 | 9.02 | 70 | 16200 | 78 | 12636 | 1796 | 49 |
5151 | 15 | 7.20 | 76 | 1230 | 88 | 1082 | 171 | 60 |
Median (range) | 16 (8-34) | 6.6 (0.74-19.2) | 65 (11-87) | 1230 (119-16 200) | 86 (62-97) | 1058 (74-12636) | 211 (13-1796) | 85.5 (39-95) |
reg indicates regulatory T cell; TNC, total nucleated cell; and UPN, unique patient number.
The UPN column is listed by the order of patient accrual and treatment in the protocol.